A new Houston-based technology seeks to allow the body to produce its own diabetes-managing peptides.
Live Poll
Would you prefer a one-time treatment over recurring injections for chronic health management?
The federal agency raised concerns about the manufacturing and clinical oversight of compounded medications for local patients.
Live Poll
Should medical research prioritize noninvasive device-based treatments for cancer-related symptoms?
Houston patients with pancreatic cancer may soon enroll in a new study testing a noninvasive device to treat cachexia.
Live Poll
Is now a good time to open your windows for better indoor air quality?
The popular ventilation practice could trigger respiratory issues for Houston residents due to the city's high humidity.
Live Poll
Does evidence of improved safety in drug trials increase your trust in new medical treatments?
A new pooled analysis suggests this treatment option maintains heart function during cancer therapy.
Live Poll
Should federal research funding prioritize identifying rare genetic causes for newly recognized neurodevelopmental disorders?
Researchers found a rare BMPR2 gene mutation in children that may offer new insights into neurodevelopmental disorders.
